Chronic Hepatitis B Virus Infection

2

Review clinical trials related to Chronic Hepatitis B Virus Infection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B

This study will examine the safety and tolerability of single and multiple doses of IB-001, and will be conducted in two parts: Part A: SAD study in approximately 50 Healthy Volunteers (HV). Part B: MAD study in approximately 30 adult participants living with Chronic Hepatitis B (CHB).

Participants needed: 80
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: IntegerBioUpdated: Jul 2, 2026Locations: 2
Eligibility criteria

Able and willing to provide written informed consent. [+3]

Major surgery requiring general anesthesia within 12 weeks prior to Screening or... [+57]

Status: Recruiting

Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection

Study HH006-202 is designed to assesses the efficacy and safety of HH-006 in adults chronic HBV infection. Eligible participants will receive study treatment for 48 weeks. All treated patients will also undergo a follow-up period after last study drug treatment.

Participants needed: 45
Trial details
Phase: Phase 2Age: 18-45Biological sex: AllType: InterventionalSponsor: Huahui HealthUpdated: Jun 15, 2026Locations: 1
Eligibility criteria

Sex: male or female; Age: 18 to 45 years old (inclusive); [+5]

Co-infected with hepatitis C, syphilis, or human immunodeficiency virus (HIV); [+19]